Incyclix Bio (formerly known Arc Therapeutics) is a cell cycle control company providing treatments that target the aberrant proliferation driving cancers. It specializes in cyclin-dependent kinases (CDKs) and their role in the cell cycle as therapeutic targets across a variety of tumor types, including ovarian, breast, and lung cancers.